BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: da Silva-Júnior EF, Leoncini GO, Rodrigues ÉES, Aquino TM, Araújo-Júnior JX. The medicinal chemistry of Chikungunya virus. Bioorg Med Chem 2017;25:4219-44. [PMID: 28689975 DOI: 10.1016/j.bmc.2017.06.049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Freitas TR, Novais RM, Santos IA, Martins DOS, Danuello A, da Silva Bolzani V, Jardim ACG, Pivatto M. In vitro antiviral activity of piperidine alkaloids from Senna spectabilis flowers on Chikungunya virus infection. Pharmacol Rep 2022. [PMID: 35882766 DOI: 10.1007/s43440-022-00381-0] [Reference Citation Analysis]
2 Hwu JR, Kapoor M, Gupta NK, Tsay S, Huang W, Tan K, Hu Y, Lyssen P, Neyts J. Synthesis and antiviral activities of quinazolinamine–coumarin conjugates toward chikungunya and hepatitis C viruses. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kumar S, Garg C, Kaushik S, Buttar HS, Garg M. Demystifying therapeutic potential of medicinal plants against chikungunya virus. Indian J Pharmacol 2021;53:403-11. [PMID: 34854411 DOI: 10.4103/ijp.IJP_81_20] [Reference Citation Analysis]
4 Fajardo TCG, Gazeta RE, Catalan DT, Mello AS, Silva ACBD, Bertozzi APAP, Santos GRD, Pinto CAL, Monteiro CO, Machado RRG, Oliveira DBL, Durigon EL, Passos SD. Neonatal consequences of maternal exposure to the chikungunya virus: Case reports. Medicine (Baltimore) 2021;100:e25695. [PMID: 33907147 DOI: 10.1097/MD.0000000000025695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ahmed SK, Haese NN, Cowan JT, Pathak V, Moukha-Chafiq O, Smith VJ, Rodzinak KJ, Ahmad F, Zhang S, Bonin KM, Streblow AD, Streblow CE, Kreklywich CN, Morrison C, Sarkar S, Moorman N, Sander W, Allen R, DeFilippis V, Tekwani BL, Wu M, Hirsch AJ, Smith JL, Tower NA, Rasmussen L, Bostwick R, Maddry JA, Ananthan S, Gerdes JM, Augelli-Szafran CE, Suto MJ, Morrison TE, Heise MT, Streblow DN, Pathak AK. Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors. J Med Chem 2021;64:4762-86. [PMID: 33835811 DOI: 10.1021/acs.jmedchem.0c02183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ivanova L, Rausalu K, Žusinaite E, Tammiku-Taul J, Merits A, Karelson M. 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors. ACS Omega 2021;6:5786-94. [PMID: 33681617 DOI: 10.1021/acsomega.0c06191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Pereira AKDS, Santos IA, da Silva WW, Nogueira FAR, Bergamini FRG, Jardim ACG, Corbi PP. Memantine hydrochloride: a drug to be repurposed against Chikungunya virus? Pharmacol Rep 2021;73:954-61. [PMID: 33523405 DOI: 10.1007/s43440-021-00216-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 da Silva Rodrigues ÉE, de Araújo-júnior JX, Anderson L, Bassi ÊJ, da Silva-júnior EF. The role of natural and nature-based compounds against Chikungunya and Mayaro alphaviruses and their vectors. Bioactive Natural Products 2021. [DOI: 10.1016/b978-0-12-819485-0.00006-2] [Reference Citation Analysis]
9 Kumar S, Garg C, Kaushik S, Buttar HS, Garg M. Demystifying therapeutic potential of medicinal plants against chikungunya virus. Indian J Pharmacol 2021;53:403-11. [PMID: 34854411 DOI: 10.4103/ijp.IJP_81_20] [Reference Citation Analysis]
10 Rodrigues ÉEDS, Maus H, Hammerschmidt SJ, Ruggieri A, dos Santos EC, Bassi ÊJ, Anderson L, Aquino PGV, de Araújo-júnior JX, Wei F, Liu X, Zhan P, Schirmeister T, da Silva-júnior EF. The Medicinal Chemistry of Zika Virus. Human Viruses: Diseases, Treatments and Vaccines 2021. [DOI: 10.1007/978-3-030-71165-8_13] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Santana AC, Silva Filho RC, Menezes JCJMDS, Allonso D, Campos VR. Nitrogen-Based Heterocyclic Compounds: A Promising Class of Antiviral Agents against Chikungunya Virus. Life (Basel) 2020;11:16. [PMID: 33396631 DOI: 10.3390/life11010016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 de Oliveira DM, Santos IA, Martins DOS, Gonçalves YG, Cardoso-Sousa L, Sabino-Silva R, Von Poelhsitz G, Franca EF, Nicolau-Junior N, Pacca CC, Merits A, Harris M, Jardim ACG. Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells. Front Microbiol 2020;11:608924. [PMID: 33384677 DOI: 10.3389/fmicb.2020.608924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Hucke FIL, Bugert JJ. Current and Promising Antivirals Against Chikungunya Virus. Front Public Health 2020;8:618624. [PMID: 33384981 DOI: 10.3389/fpubh.2020.618624] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
14 Passos GFS, Gomes MGM, Aquino TM, Araújo-Júnior JX, Souza SJM, Cavalcante JPM, Santos ECD, Bassi ÊJ, Silva-Júnior EFD. Computer-Aided Design, Synthesis, and Antiviral Evaluation of Novel Acrylamides as Potential Inhibitors of E3-E2-E1 Glycoproteins Complex from Chikungunya Virus. Pharmaceuticals (Basel) 2020;13:E141. [PMID: 32629969 DOI: 10.3390/ph13070141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
15 Moesslacher J, Battisti V, Delang L, Neyts J, Abdelnabi R, Pürstinger G, Urban E, Langer T. Identification of 2-(4-(Phenylsulfonyl)piperazine-1-yl)pyrimidine Analogues as Novel Inhibitors of Chikungunya Virus. ACS Med Chem Lett 2020;11:906-12. [PMID: 32435404 DOI: 10.1021/acsmedchemlett.9b00662] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ghildiyal R, Gabrani R. Antiviral therapeutics for chikungunya virus. Expert Opin Ther Pat 2020;30:467-80. [PMID: 32249636 DOI: 10.1080/13543776.2020.1751817] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
17 Silva S, Shimizu JF, Oliveira DM, Assis LR, Bittar C, Mottin M, Sousa BKP, Mesquita NCMR, Regasini LO, Rahal P, Oliva G, Perryman AL, Ekins S, Andrade CH, Goulart LR, Sabino-Silva R, Merits A, Harris M, Jardim ACG. A diarylamine derived from anthranilic acid inhibits ZIKV replication. Sci Rep 2019;9:17703. [PMID: 31776405 DOI: 10.1038/s41598-019-54169-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
18 Pérez-pérez M, Delang L, Ng LFP, Priego E. Chikungunya virus drug discovery: still a long way to go? Expert Opinion on Drug Discovery 2019;14:855-66. [DOI: 10.1080/17460441.2019.1629413] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
19 Monteiro VVS, Navegantes-Lima KC, de Lemos AB, da Silva GL, de Souza Gomes R, Reis JF, Rodrigues Junior LC, da Silva OS, Romão PRT, Monteiro MC. Aedes-Chikungunya Virus Interaction: Key Role of Vector Midguts Microbiota and Its Saliva in the Host Infection. Front Microbiol 2019;10:492. [PMID: 31024463 DOI: 10.3389/fmicb.2019.00492] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
20 de Godoy AS, Sachetto Fernandes R, Campos Aguiar AC, Vieira Bueno R, de Moraes Roso Mesquita NC, Carvalho Guido RV, Oliva G. Structural and mechanistic insight from antiviral and antiparasitic enzyme drug targets for tropical infectious diseases. Curr Opin Struct Biol 2019;59:65-72. [PMID: 30954758 DOI: 10.1016/j.sbi.2019.02.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ferreira AC, Reis PA, de Freitas CS, Sacramento CQ, Villas Bôas Hoelz L, Bastos MM, Mattos M, Rocha N, Gomes de Azevedo Quintanilha I, da Silva Gouveia Pedrosa C, Rocha Quintino Souza L, Correia Loiola E, Trindade P, Rangel Vieira Y, Barbosa-Lima G, de Castro Faria Neto HC, Boechat N, Rehen SK, Brüning K, Bozza FA, Bozza PT, Souza TML. Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication. Antimicrob Agents Chemother 2019;63:e01389-18. [PMID: 30455237 DOI: 10.1128/AAC.01389-18] [Cited by in Crossref: 42] [Cited by in F6Publishing: 53] [Article Influence: 10.5] [Reference Citation Analysis]
22 Hwu JR, Huang WC, Lin SY, Tan KT, Hu YC, Shieh FK, Bachurin SO, Ustyugov A, Tsay SC. Chikungunya virus inhibition by synthetic coumarin-guanosine conjugates. Eur J Med Chem 2019;166:136-43. [PMID: 30703657 DOI: 10.1016/j.ejmech.2019.01.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
23 Gómez-SanJuan A, Gamo AM, Delang L, Pérez-Sánchez A, Amrun SN, Abdelnabi R, Jacobs S, Priego EM, Camarasa MJ, Jochmans D, Leyssen P, Ng LFP, Querat G, Neyts J, Pérez-Pérez MJ. Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. ACS Infect Dis 2018;4:605-19. [PMID: 29406692 DOI: 10.1021/acsinfecdis.7b00219] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
24 Brown RS, Wan JJ, Kielian M. The Alphavirus Exit Pathway: What We Know and What We Wish We Knew. Viruses 2018;10:E89. [PMID: 29470397 DOI: 10.3390/v10020089] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 10.6] [Reference Citation Analysis]